Medication info
Memantine 10mg (Memantine Hydrochloride)

Memantine 10mg (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
Vivozon Pharmaceutical Co., Ltd.
Appearance
White rectangular film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201901764 · Approved 2019.03.25 · Insurance code 658204740

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
This medicine is administered orally once daily, at the same time each day. If necessary, it may be administered twice daily. It may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (days 1~7) Administer 5mg daily for 7 days. Week 2 (days 8~14) Administer 10mg daily for 7 days. Week 3 (days 15~21) Administer 15mg daily for 7 days. From week 4 onward Administer 20mg daily. Maintenance dose: The recommended maintenance dose is 20mg daily. 2. Older adults: Based on clinical data, the recommended dose for patients aged 65 years and older is 20mg daily. 3. Patients with renal impairment: No dose adjustment is required in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), reduce the daily dose to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg daily according to the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), reduce the daily dose to 10mg. 4. Patients with hepatic impairment: No dose adjustment is required in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since data on the use of memantine in patients with severe hepatic impairment are unavailable, it is preferable not to administer this medicine.

Ingredients

Manufacturer
Vivozon Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

  • Alzheimer's disease
View approved original text

This medication is used for the treatment of moderate to severe Alzheimer's disease.

How to take

Adult dose

This medicine is administered orally once daily, at the same time each day. If necessary, it may be administered twice daily. It may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (days 1~7) Administer 5mg daily for 7 days. Week 2 (days 8~14) Administer 10mg daily for 7 days. Week 3 (days 15~21) Administer 15mg daily for 7 days. From week 4 onward Administer 20mg daily. Maintenance dose: The recommended maintenance dose is 20mg daily. 2. Older adults: Based on clinical data, the recommended dose for patients aged 65 years and older is 20mg daily. 3. Patients with renal impairment: No dose adjustment is required in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), reduce the daily dose to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg daily according to the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), reduce the daily dose to 10mg. 4. Patients with hepatic impairment: No dose adjustment is required in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since data on the use of memantine in patients with severe hepatic impairment are unavailable, it is preferable not to administer this medicine.

Precautions

This medication should not be used in patients with an allergy to any ingredient in this product. It is also safe to refrain from administering this drug to patients with very poor liver function or severely impaired kidney function. Patients with epilepsy or a history of convulsions, as well as those prone to seizures, should use this drug with caution. Concurrent use with other medications that have similar effects may increase central nervous system side effects; therefore, they should not be combined. Patients with conditions that may alter urine acidity (pH) or dietary changes should carefully monitor their urine status while taking this medication. The safety of this drug has not been established in patients with heart disease or uncontrolled hypertension, thus it should be used cautiously. Side effects such as dizziness, headache, constipation, drowsiness, and hypertension may occur while taking this medication; if symptoms are severe, consult a physician. There may be interactions with other drugs, so it is particularly advised to consult a professional if taking antipsychotic medications, muscle relaxants, or anticoagulants. Women who are pregnant or may become pregnant should make careful decisions regarding the potential risks to the fetus when using this medication. If breastfeeding, it is recommended to discontinue nursing, as this drug may be transmitted through breast milk. The safety and effectiveness of this medication have not been established in children and adolescents under 18 years of age, so it is advisable not to use it in this population. In the event of overdose, symptoms such as confusion, drowsiness, dizziness, and vomiting may occur, necessitating immediate medical attention. This medication may affect a patient’s reaction time, so caution is needed when driving or operating machinery. Store in a safe place out of reach of children and do not transfer the medication to another container.

Side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity reaction
  • confusion
  • hallucinations
  • psychotic reactions
Show 19 more
  • balance disorder
  • gait abnormality
  • seizures
  • heart failure
  • venous thromboembolism/thrombosis
  • dyspnea
  • vomiting
  • pancreatitis
  • elevated liver function test results
  • hepatitis
  • fatigue
  • nonspecific fatigue
  • weakness
  • diarrhea
  • restlessness
  • aggression
  • stupor
  • unconsciousness
  • diplopia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture from entering. Additionally, it should be kept at room temperature between 1 to 30 degrees Celsius, away from extreme heat or cold.

Appearance and packaging

Appearance

White rectangular film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.